Potential Disease Targets for Drugs that Disrupt Protein - Protein Interactions of Grb2 and Crk Family Adaptors
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
529-548
Author(s):
Stephan M. Feller and Marc Lewitzky
Antioxidant Vitamins and Risk of Lung Cancer
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
599-613
Author(s):
A. Ruano-Ravina, A. Figueiras, M. Freire-Garabal and J. M. Barros-Dios
C5,C6-Disubstituted 1H-Indole-2-Carboxamides: Synthesis and Cytotoxic Activity in the Human Non-Small Lung Cancer Cell Line NSCLC-N16-L16
Journal:
Letters in Drug Design & Discovery
Volume:
3
Page:
14-16
Author(s):
Andrew Tsotinis, Maria Gerasimopoulou, Margarita Vlachou, Dimitri Moreau and Christos Roussakis
Estrogen Receptors as Therapeutic Targets in Breast Cancer
Journal:
Current Topics in Medicinal Chemistry
Volume:
6
Page:
181-202
Author(s):
Eric A. Ariazi, Jennifer L. Ariazi, Fernando Cordera and V. Craig Jordan
Matrix Metalloproteinase Inhibitors as Prospective Agents for the Prevention and Treatment of Cardiovascular and Neoplastic Diseases
Journal:
Current Topics in Medicinal Chemistry
Volume:
6
Page:
289-316
Author(s):
Qing-Xiang A. Sang, Yonghao Jin, Robert G. Newcomer, Sara C. Monroe, Xuexun Fang, Douglas R. Hurst, Seakwoo Lee, Qiang Cao and Martin A. Schwartz
Peptide Phage Display: Opportunities for Development of Personalized Anti-Cancer Strategies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
9-17
Author(s):
T.I. Samoylova, N.E. Morrison, L.P. Globa and N.R. Cox
Marine Peptides and Related Compounds in Clinical Trial+
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
33-40
Author(s):
Diwan S. Rawat, Mukesh C. Joshi, Penny Joshi and Himanshu Atheaya
Understanding Apoptosis in Terms of QSAR
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
41-52
Author(s):
Rajeshwar P. Verma
Host Pharmacogenetics in the Treatment of HIV and Cancer
Journal:
Current Drug Safety
Volume:
1
Page:
107-116
Author(s):
Alan Winston, Eleftheria Hatzimichael, Vanessa Marvin, Justin Stebbing and Mark Bower
Current State of the Art of New Tubulin Inhibitors in the Clinic
Journal:
Current Clinical Pharmacology
Volume:
1
Page:
57-70
Author(s):
Isa E.L.M. Kuppens